- Published at
- by seekingalpha.com
positive
positive
Spyre Therapeutics: Different Name, Same Tune (NASDAQ:SYRE)
Spyre Therapeutics, Inc. has promising assets in early-stage development, including SPY001, SPY002, and SPY003. Learn more about SYRE stock here.